Skip to content

Comparison of vaginal Misoprostol versus Foley catheter for labor induction

Comparison the results of induction of vaginal misoprostol with Foley catheter in prolonged pregnancy with unripe cervix

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017052710340N13
Enrollment
60
Registered
2017-06-26
Start date
2017-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pregnancy. Pregnancy, childbirth and the puerperium

Interventions

Intervention 1: Foley catheter 16. Intervention 2: 25 mcg tablets of misoprostol ?? posterior vaginal fornix.
Treatment - Other
Treatment - Drugs
Foley catheter 16
25 mcg tablets of misoprostol ?? posterior vaginal fornix

Sponsors

Vice chancellor for research, Golestan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: Cephalic presentation; healthy amnion; Bishop score less than 6; inappropriate cervix; inappropriate uterine contractions; normal fetal heart rate. Exclusion criteria was considered as : Pelvic dystocia; fetal weight more than 4 kg; incompatibility of fetal head with maternal pelvis ; placenta praevia; unexplained vaginal bleeding; the parity more than five; fetal anomaly; previous uterine scar; any situation that makes vaginal delivery impossible.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Labor induction. Timepoint: The first, second and third phase of delivery. Method of measurement: Stopwatch.

Secondary

MeasureTime frame
Apgar. Timepoint: The first minute after the baby is born. Method of measurement: Apgar score.;Bleeding. Timepoint: After delivery. Method of measurement: The number of bleeding pads.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGhazal Goli

Golestan University of Medical Science

ghazalakjoon65@yahoo.com+98 17 3242 4377

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026